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of-use#LAAWith the increased life expectancy in the 
German population, the proportion of 
deaths from leading causes such as can-
cer, coronary heart diseases and stroke 
will further increase [1, 2]. Numerous 
risk factors for the major disease-relat-
ed causes of death are already known and 
have been characterized including smok-
ing, alcohol, physical activity and nutri-
tion. The role of bacterial and viral infec-
tions, chronic inflammatory processes or 
impairment of the immune system in the 
development of the diseases named above 
still have to be assessed.
Starting in 2014, the German Nation-
al Cohort (GNC), a large nationwide pro-
spective cohort study with an anticipated 
sample of 200,000 individuals between the 
ages of 20 and 69 years, will collect infor-
mation on the current and former health 
status of the German population as well as 
store the individual’s biosamples such as 
blood, urine, stool and nasal swab [3, 4].
One of the distinguished aspects of the 
GNC compared to other national and in-
ternational prospective cohort studies 
will be the assessment of infectious dis-
eases. The Working Group Infection & 
Immunity of the GNC identified five top-
ics (T) for which a cohort study within an 
aging population is an ideal and unique 
approach to be addressed. These are im-
mune senescence/dysfunction and vac-
cines (T1), chronic viral infections (T2), 
respiratory infections (T3), bacterial in-
fections (including resistance factors) 
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infections (T5). To address T1, vaccina-
tion status and non-infectious risk fac-
tors have to be determined. T2–T5 are 
based on a determination of incidence 
and burden of infections, amongst oth-
ers. To assess these questions a new infec-
tious disease questionnaire (ID Screen) 
as complementary tool to a comprehen-
sive medical standardized interview (core 
questionnaire) was developed to identi-
fy individuals at risk of immune dysfunc-
tion. Furthermore, it assesses frequent in-
fections as well as exposure to pets and 
animal husbandry to identify potential 
sources of zoonotic diseases. Parts of the 
questionnaire are based on the immune 
system assessment questionnaire (ISAQ), 
developed at the Center for Chronic Im-
munodeficiency, University Medical 
Center Freiburg [5].
As the ID Screen was for the first time 
applied in Pretest 1, the first feasibili-
ty study of the GNC, an evaluation con-
cerning its feasibility and validity is nec-
essary. The ID Screens basic require-
ments were that it should (1) be self-ad-
ministered and self-reported, (2) be short 
(less than 10 min to complete), (3) mea-
sure infections including resistance fac-
tors, (4) measure susceptibility to infec-
tions and immune status and (5) be reli-
able and valid.
To evaluate the feasibility and validity 
of the ID Screen as well as the potential 
for its application as a take-home ques-
tionnaire compared to an on-site ques-
tionnaire, four study centers participated 
in implementing the ID Screen.
Methods
Study design
The examination of subjects during Pre-
test 1 took place from August–November 
2011; subjects between the ages of 20–
69 years were recruited via random sam-
pling through the regional registration of-
fices. Due to oversampling of older par-
ticipants, the envisaged distribution was 
10 % for the age groups 20–29 and 30–39 
and 26.7 % for the age groups 40–49, 50–
59 and 60–69. Protocols for further re-
cruitment procedures, like area-based re-
cruitment, follow-up for nonresponders 
and incentives were developed indepen-
dently in each study center.
Participants undertook a medical ex-
amination as well as the GNC core ques-
tionnaire assessing health and dietary as-
pects on-site. Four study centers, Bre-
men, Hamburg, Heidelberg and Freiburg 
additionally applied the ID Screen, with 
Bremen and Hamburg providing a take-
home questionnaire to be picked up lat-
er by study center personnel and Heidel-
berg and Freiburg conducting an on-site 
questionnaire. Participation was limited 
to subjects with sufficient knowledge of 
the German language.
ID Screen
The ID Screen was a self-report and self-
administered questionnaire, divided in-
to six sections (S): 12-month cumulative 
incidence of certain infections (S1), life-
time prevalence of certain infectious dis-
eases (S2), utilization of health care facili-
ties (S3), 12-month cumulative incidence 
of antibiotic intake (S4), vaccination sta-
tus for influenza and pneumococcal in-
fection (S5) and contact to pets (S6), en-
compassing in total 77 variables. Only the 
33 nonfilter questions that could be an-
swered independent of the prior answer 
being yes, were evaluated. See supplemen-
tary material for the complete translated 
questionnaire.
Core questionnaire
The ID Screen is a complementary tool 
to the computer-assisted personal inter-
viewing (CAPI), assessing the compre-
hensive medical state of the participants. 
The following 8 items of this core ques-
tionnaire were used in the evaluation of 
the ID Screen:
“Has a physician ever diagnosed [rheu-
matic diseases (1); autoimmune diseases 
(2); diseases of the skin (3); asthma (4); 
allergies (5): hay fever, bee venom, food, 
dust mites, animal hair, contact allergy, 
drug allergy; chickenpox (6); shingles (7); 
sepsis (8)]?” to be answered with “yes”, 
“no” or “don’t know”.
Feasibility/validity
To assess the feasibility of the ID Screen, 
aspects concerning time for completion 
and compliance especially with regard to 
the different fill in scenarios (take-home 
vs. on-site) were evaluated. The compli-
ance is reflected in the participation and 
the total number of missing values per 
participant for the 33 nonfilter questions, 
with an incomplete questionnaire being 
defined as more than 50 % of the ques-
tions containing missing values.
Internal validity
Aspects of internal validity were ad-
dressed by analyzing the frequency of 
missing, “don’t know” and “no answer” 
values for the 33 nonfilter questions; a 
frequency < 5 % was considered accept-
able. Comments by participants were 
taken into consideration to evaluate 
comprehension of the ID Screen. Fur-
thermore, a direct comparison of related 
questions, such as 12-month prevalence/
lifetime infection and antibiotic prescrip-
tions/use of health care facilities was 
used, to assess unsuitably phrased ques-
tions leading to a lack of understanding 
by the participants. To evaluate the use-
fulness of the categorical scale used for 
the items in section S1 and S4, the fre-
quency with which each category was an-
swered was measured.
Reliability
To assess the reliability, the agreement be-
tween answers for duplicate variables in 
the core questionnaire of the GNC and 
the ID Screen, Cohen’s κ was calculated. 
The proposed interpretation for strength 
of agreement is 0: poor; 0.01–0.2 slight; 
0.21–0.40: fair; 0.41–0.60: moderate; 0.61–
0.80: substantial and 0.81–1: almost per-
fect [6].
Construct validity
The ID Screen was designed as a tool to 
measure amongst others (1) susceptibility 
to infections and (2) immune status. Ex-
ploratory factor analysis (EFA) was used 
with the aim to create a score for each 
of the two constructs. The variables in-
cluded in the construct “susceptibility”, 
all variables from section 1, were recod-
ed to present the midpoints over the cate-
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Abstract
Background/objectives.  The risk to die from 
an infectious disease in Germany has been 
continuously decreasing over the last cen-
tury. Since infections are, however, not on-
ly causes of death but risk factors for diseases 
like cardiovascular diseases, it is essential to 
monitor and analyze their prevalence and fre-
quency, especially in consideration of the in-
creased life expectancy. To gain more knowl-
edge about infectious diseases as risk fac-
tors and their implications on the condition 
and change of the immune status, the Ger-
man National Cohort (GNC), a population-
based prospective cohort study, will recruit 
200,000 subjects between 2014 and 2017. In 
Pretest 1, a feasibility study for the GNC, we 
evaluated a self-administered and self-report 
questionnaire on infectious diseases and on 
the use of health care facilities (hereinafter 
called “ID Screen”) for feasibility and validity.
Methods.  From August–November 2011, 
435 participants between the ages of 20–
69 completed the ID Screen. All subjects had 
been recruited via a random sample from the 
local residents’ registration offices by 4 of the 
18 participating study centers. The question-
naire encompasses 77 variables in six sections 
assessing items such as 12-month prevalence 
of infections, cumulative prevalence of infec-
tious diseases, visit of health care facilities and 
vaccination. The feasibility was amongst oth-
ers evaluated by assessing the completeness 
and comprehensiveness of the questionnaire. 
To assess the questionnaires ability to mea-
sure “immune status” and “susceptibility to in-
fections”, multivariate analysis was used.
Results.  The overall practicability was good 
and most items were well understood, dem-
onstrated by < 2/33 missing questions per 
questionnaire and only three variables: vac-
cination for influenza and pneumococci and 
infection with chickenpox had a frequen-
cy > 5 % of missing values. However, direct 
comparison of the items 12-month preva-
lence and lifetime prevalence of nephritis/
pyelitis showed poor agreement and there-
by poor understanding by 80 % of the partici-
pants, illustrating the necessity for a clear, lay 
person appropriate description of rare diseas-
es to increase comprehensibility. The ques-
tionnaire will be used to support the assess-
ment of immune dysfunction and frequency 
of infection. An analysis of these constructs 
in an exploratory factor analysis revealed lim-
ited applicability due to low interitem corre-
lation (Cronbach’s α < 0.5). This is corroborat-
ed by the extraction of more than one factor 
with a Kaiser–Meyer–Olkin measure of 0.6 in-
stead of a unidimensional latent construct for 
“immune status”.
Conclusion.  All in all, the ID Screen is a good 
and reliable tool to measure infectious dis-
eases as risk factors and outcome in general, 
but requires a better translation of infection 
specific terms into lay person terms. For the 
assessment of the overall immune status, the 
tool has strong limitations. Vaccinations sta-
tus should also rather be assessed based on 
vaccination certificates than on participants’ 
recall.
Keywords
Survey validity · Infections · Questionnaires · 
Self-report · German National Cohort (GNC)
Evaluierung eines Fragebogens zur Erfassung von Infektionen und relevanten Risikofaktoren.  
Ergebnisse einer multizentrischen Studie
Zusammenfassung
Einführung/Ziele. Infektionskrankheiten 
sind in Industrieländern nicht mehr die füh-
renden Ursachen für Morbidität und Mortali-
tät. Als Risikofaktoren für nichtübertragbare, 
wie z. B. kardiovaskuläre Krankheiten, spie-
len sie jedoch nach wie vor eine wichtige Rol-
le. In der Nationalen Kohorte (NaKo), einer 
prospektiven Kohortenstudie, die zwischen 
2014 und 2017 in Deutschland den Gesund-
heitszustand von 200.000 Bürgern misst, ist 
die Erfassung von Infektionen und ihren Risi-
kofaktoren eine hervorgehobene Komponen-
te. Im Pretest 1 zur NaKo wurde ein Fragebo-
gen, der u. a. Infektionen und medizinische 
Behandlungen mittels Selbstangabe und 
Selbsteinschätzung erfasst (ID-Screen), auf 
Machbarkeit und Vollständigkeit evaluiert.
Methode.  Im Zeitraum von August bis No-
vember 2011 füllten in 4 der 18 teilnehmen-
den Studienzentren 435 über die Einwoh-
nermeldeämter ermittelte Probanden im Al-
ter zwischen 20 und 69 den Fragebogen 
aus. Dieser bestand aus 77 Variablen in 6 Ab-
schnitten und erfasste unter anderem 12-Mo-
nats- und Lebenszeitprävalenzen von Infek-
tionen, Klinikbesuchen und Impfungen. Zur 
Evaluierung wurden die Ergebnisse auf Voll-
ständigkeit und Verständnis überprüft. Zu-
dem wurde mittels multivariater Analyse er-
mittelt, ob der Fragebogen wie geplant den 
Immunstatus und die Infektanfälligkeit er-
fasst.
Ergebnis.  Der Fragenbogen war gut ver-
ständlich und wurde von den Probanden ak-
zeptiert, wie man der geringen Zahl an feh-
lenden Daten pro Fragebogen (< 2/33 Fra-
gen) entnehmen konnte. Zudem hatten nur 
die 3 Fragen zu Impfungen gegen Influen-
za, Impfungen gegen Pneumokokken sowie 
zu Infektionen mit Windpocken mehr als 5 % 
fehlende Messwerte. Vergleicht man die Er-
fassung der 12-Monats-Prävalenz und der Le-
benszeitprävalenz für Nieren-/Nierenbecken-
infektionen, so findet man bei 4 von den 5 
betroffenen Probanden (80 %) eine mangeln-
de Übereinstimmung. Dies verdeutlicht, dass 
medizinische Begriffe und seltene Erkran-
kungen für Laien als Zielpersonen entspre-
chend erklärt werden müssen. Um die Eig-
nung des ID-Screens zur Messung des Im-
munstatus und der Infektanfälligkeit zu be-
stimmen, wurde eine explorative Faktoren-
analyse durchgeführt. Hier hat sich u. a. ge-
zeigt, dass für das Konstrukt „Immunstatus“ 
eine zu geringe Inter-Item-Korrelation (Cron-
bach’s α < 0,5) vorliegt und mit einem KMO 
von 0,6 mehr als ein Faktor extrahiert wur-
de. Somit lässt sich der Immunstatus mit dem 
ID-Screen nicht als eine latente Variable ab-
bilden.
Schlussfolgerung.  Der Fragebogen ist ein 
geeignetes Instrument, um Infektionskrank-
heiten zu erfassen. Für Laien als Zielgruppe 
sollten Fachbegriffe jedoch besser übersetzt 
werden. Um den Immunstatus als solchen 
zu erfassen, hat der ID-Screen starke Ein-
schränkungen. Statt in einer erinnerungsba-
sierten Impfabfrage sollten Impfungen bes-
ser über die Informationen im Impfpass er-
fasst werden.
Schlüsselwörter
Infektionen · Fragebogen zu 
Infektionskrankheiten · Selbsteinschätzung · 
Validierung · Nationale Kohorte (NaKo)
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3.5; 5–6 times: 5.5 and more than 6 times: 
7). For the construct “immune status” the 
following variables were clustered: aller-
gies, rheumatic-, autoimmune-, skin dis-
eases and asthma from the core question-
naire of the GNC as well as the variables: 
surgery, removal of 2nd lymphoid organs, 
variables from section 1 (midpoints) and 
number of shingle episodes from the 
ID Screen. The variable “removal of the 
spleen” was removed from the analysis 
due to a conditional variance of zero. All 
non-ordinal data were recoded to dichot-
omous variables with no = 0 and yes = 1. 
“Don’t know” answers were recoded as 
missing data.
To show that there is covariation 
among the included variables, the Kai-
ser–Meyer–Olkin measure (KMO), 
where a minimum value of 0.5 is re-
quired, was used to check the sampling 
adequacy of the constructs [7]. Pearson 
correlation was used to examine the cor-
relation r between the contributing vari-
ables [8]. The internal consistency was 
examined by Cronbach’s α which can be 
interpreted as follows: α ≥ 0.9: excellent; 
0.7–0.9: good; 0.6–0.7: acceptable; 0.5–
0.6: poor and α < 0.5: unacceptable [9]. 
Applying the scree test criterion result-
ed in the extraction of one factor for the 
construct “susceptibility” and four fac-
tors for the construct “immune status”. 
For better allocation of the items per fac-
tor and therefore better interpretation of 
the factors “immune status”, an orthog-
onal rotation (Varimax) was applied 
[8]. Only variables with a factor loading 
> |0.4| are considered for interpretation 
[8, 10].
All statistical analyses except the es-
timation of confidence limits were com-
puted with SAS® 9.2. The confidence lim-
its were calculated in EXCEL 2010 using 
an approximation based on Rothman 
[11].
Results
Feasibility
Between the four study centers, 467 sub-
jects were recruited to participate in the 
medical examination and the compre-
hensive medical core questionnaire. A to-
tal of 435 (93 %) subjects participated in 
the ID Screen, with the age distribution 
between 18 and 70 years and a mean age 
of 47.4 ± 14.4 years.
General characteristics of the partic-
ipants differentiated by study center are 
shown in . Tab. 1. The participation rate 
for the take home questionnaire was 89 % 
and for the on-site questionnaire 98 %.
The mean time to fill in the question-
naire as well as the proportion of missing 
responses per questionnaire was high-
er among the take-home than the on-
site questionnaires. One of the take-home 
questionnaires was rated as incomplete 
due to 18 missing values.
Internal validity
The aspect of internal validity to be as-
sessed was the analysis of missing answers 
per variables to identify inaccurate items. 
Three variables of the categories vacci-
nation and childhood diseases showed a 
frequency of missing values > 5 %, with 
vaccination against influenza being 12 %, 
against pneumococci 25 % and lifetime 
prevalence of chickenpox infection 12 %, 
respectively.
The 12-month cumulative incidence of 
certain infections (Section 1) as well as the 
frequency of antibiotic prescriptions over 
the past 12 months (Section 4) was mea-
sured in categories from “none” to “more 
than 6 times”. The distribution of the an-
swers across the categories are shown in 
Figure 1. The item “Upper respiratory 
tract infection (URTI)” showed a full sep-
aration across the categories, with > 2 % of 
the participants being placed in the high-
est category “more than 6 times”. In con-
trast, the 12-month cumulative incidence 
for nephritis/pyelitis (kidney) is only rep-
resented by the categories “none” and “1–
2 times”. Regarding antibiotic prescription 
(ABP), only 0.9 % and 0.7 % of the partici-
pants reported a frequency of prescription 
in the two highest categories “4–6 times” 
and “more than 6 times”, respectively.
The lifetime prevalence for the infec-
tious diseases varied between 0 % (HIV) 
and 8 % (shingles) for the variables with 
a low frequency of missing values (< 5 %) 
across the 435 participants. Analysis 
stratified by study centers showed on-
ly for the frequency of chickenpox a sig-
nificant variation. Participants in Bremen 
self-reported a significantly lower fre-
quency for chickenpox than participants 
from Heidelberg (p = 0.025) and Freiburg 
(p = 0.003) (. Tab. 2).
Plotting antibiotic prescriptions 
against out-patient and in-patient care 
(. Fig. 2) was used to appraise the valid-
ity of self-reported antibiotic prescrip-
tions. A third of the participants, 143/431, 
stated to have been prescribed antibiot-
ics, of whom 9 % (13/143) did not receive 
out-patient care but had been in the hos-
pital for a non-infectious disease. Of all 
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Table 1  Characteristics of subjects by participating study centers and analysis of compliance 
and time for completion
Bremen 
n = 87
Hamburg 
n = 90
Heidelberg 
n = 105
Freiburg 
n = 156 
Women (%) 57 57 46 51
Mean age + SD (years) 49.6 ± 13.6 46.8 ± 15.6 44.1 ± 14.9 48.9 ± 13.4
Migration backgrounda (%) 33.3 30.8 37.7 26.3
Questionnaire Take home Take home Study center Study center
Participation ID Screen (%)  87 90 95 99
Median time to complete (min) 10 10 6 8
[Inter quartile range] [6–17] [6–14.5] [5–8] [5–10]
Missing responses per 
questionnaire (mean)
2.0/33 0.7/33 0.5/33 0.6/33
CI95 % 1.5–2.5 1.0–1.4 0.8–1.1 0.8–1.1
Min–max 0–18 0–12 0–9 0–9
Incomplete questionnaires 
(> 16/33 missing values)
1 – – –
Subjects receiving help from study 
nurse (n)
Not appli-
cable
Not appli-
cable
1 4
aMigrations status was determined according to Schenk et al. [12]subjects who reported having been pre-
scribed antibiotics, 41 % (58/143) did not 
visit a health care facility at all during the 
respective time period of 12 months.
Due to a duplicate request, a direct 
comparison of the answers to “12-month 
prevalence” of nephritis/pyelitis with re-
ported “lifetime prevalence” of nephritis/
pyelitis was possible and revealed that of 
the 5 participants who stated to have had 
a kidney infection in the past 12 months, 
4 (80 %) claimed to never have had a kid-
ney infection in their lifetime (diagnosed 
by a physician) or didn’t know if they had.
Reliability
The reliability of the ID Screen could part-
ly be assessed by comparing its results 
with similar questions from the core ques-
tionnaire. In the ID Screen (self-adminis-
tered) and in the core questionnaire (CA-
PI) likewise, participants were asked if 
they ever had sepsis, chickenpox or shin-
gles diagnosed by a physician. The agree-
ment between these variables was 97.3 % 
for sepsis with a κ of 0.76 (CI95 % 0.64–
0.88), 70.5 % for chickenpox with κ = 0.46 
(CI95 % 0.40–0.53) and 93.2 % agreement 
for shingles with a κ  of 0.65 (CI95 % 0.54–
0.76).
Construct validity
One aim of the ID Screen was to assess 
“susceptibility to infections”, using the 
seven items of section 1. The evaluation 
of the internal consistency resulted in a 
standardized Cronbach’s α of 0.36. One 
at a time removal of each item resulted in 
values in the range of 0.25–0.38 for this 
index. Removing the items “herpes”, “fu-
runcle” and “kidney/pelvis”, respectively, 
led to an increase of Cronbach’s α to 0.37, 
0.38 and 0.41.
EFA was used to evaluate the validity 
for the construct “susceptibility to infec-
tions” and to return a score. Due to miss-
ing data, 17 of the 435 subjects were omit-
ted from the factor analysis. The correla-
tion r was low, with |r| ranging between 
0.012 and 0.242. Four factors were re-
tained based on an Eigenvalue > 1. Ap-
plication of the scree test extracted one 
meaningful factor, with an Eigenvalue 
of 1.6, explaining 23 % of the total vari-
ance. The KMO was 0.50 and omitting 
the variables abscess/furuncle and kidney 
infection due to an individual KMO < 0.5 
would increase the overall KMO to 0.54. 
The density distribution of this factor is 
shown in Figure 3. The top 5 % of partic-
ipants of the ID Screen had a score value 
> 1.6 and were considered highly suscepti-
ble for infections.
To evaluate if the ID Screen contrib-
utes to assessing the immune status, an 
EFA was performed with items judged to 
be relevant to influence and measure im-
mune function (see methods).
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Fig. 2 8 Antibiotic prescription in association with doctor’s visits. A to-
tal of 429/435 participants answered the question for antibiotics prescrip-
tion (6 missing data): 143 (33 %) of the participants self-reported to have re-
ceived antibiotic prescriptions in the past 12 months, out of which 72 (50 %) 
did not receive out-patient care. A subanalysis of these participants for in-
patient care revealed that 14 received in-patient care and 58, equivalent to 
41 % of participants, claiming to have received an antibiotic prescription, 
did not visit a physician in either in-patient or out-patient care
 
Fig. 1 8 Separation of data points for 12-month prevalence of infections and antibiotic prescription 
across the categories. In section 1 of the ID Screen the 12-month prevalence of the infections: upper 
respiratory tract infections (URTI), lower respiratory tract infections (LRTI), gastrointestinal infections 
(GTI), infections of the skin-herpes/warts (herpes) and furuncle/abscess (furuncle), urinary tract infec-
tions-bladder (UTI) and nephritis/pyelitis (kidney) were assessed as categorical data using the cate-
gories (c2–c7): none (c2); 1–2 times (c3); 3–4 times (c4); 5–6 times (c5); more than 6 times (c6); don’t 
know (c7). In section 4 of the ID Screen, antibiotic prescription (ABP) was assessed using the catego-
ries (c2–c6): none (c2); 1–3 times (c3); 4–6 times (c4); more than 6 times (c5) don’t know (c6). Missing 
values for both sections are depicted in category c1. For section 1 the full categorical range is used, ex-
emplified by URTI, which show a good separation across all the categories, with 2 % of participants be-
ing placed in the highest category c6 “more than 6 times”. For antibiotic prescription, categories with a 
slightly different range were chosen, which are not fully exploited: 96 % of the data points are distrib-
uted across the categories none (c2) and 1–3 times (c3).
 The correlation ranged between 
|r| = 0.0001 and 0.65 and raw Cronbach’s 
α was 0.42. Removing the item “12-month 
prevalence of herpes/warts” would lead to 
an increase of Cronbach’s α to 0.45.
For the EFA 46 subjects were omitted 
from the analysis due to missing values. 
Nine factors were extracted based on an 
Eigenvalue > 1 and a scree test reduced the 
extracted factors to four, explaining 31 % 
of the total variance. The KMO was 0.60. 
The factor loadings above |0.4| for the in-
cluded items are presented in . Table 3.
Variables positively loading into the 
first factor were allergies and asthma. 
The second factor was a combination of 
drug allergy and the 12-month preva-
lence of upper respiratory tract, gastroin-
testinal tract and urinary tract infection. 
The variables loading into the third fac-
tor were removal of the thymus, shingles 
and 12-month prevalence of kidney infec-
tion. The fourth factor contains removal 
of tonsils and adenoid glands and surger-
ies in general.
Discussion
We evaluated the ID Screen for its assess-
ment of infections including resistance 
factors and its applicability as a self-re-
port and self-administered tool to mea-
sure susceptibility to infections and im-
mune status in a population-based study.
Feasibility
With a participation rate between 87 % 
and 99 % and a range of 0.5–2 missing an-
swers per questionnaire, the ID Screen 
turned out to be comprehensible and easy 
to use. Only one participant returned an 
incomplete form. However, comparing 
the results between the take-home and 
on-site approach returns a higher partici-
pations rate and shorter fill-in time for the 
on-site approach.
Internal validity
An important aspect for the applicabili-
ty of the ID Screen to assess susceptibili-
ty to infections and immune status is the 
full use of the applied categories for the re-
spective items.
Both the sections 12-month prevalence 
of infections and prescription of antibiot-
ics used six and five categories, respec-
tively, from “none” to “more than 6 times” 
and “don’t know”. While 12-month preva-
lence of infections was covered adequate-
ly by these categories with URTI using all 
possible categories by at least 2 % of the 
participants, too many categories were ap-
plied to measure ABP (. Fig. 1). The an-
swer categories “4–6 times” and “more 
than 6 times” together were checked by 
only 1.6 % of the participants, thereby ba-
sically converting a categorized variable 
into a dichotomous variable (yes or no).
The direct comparison of the dual 
questions for an infection of the kidney 
or renal pelvis, once for 12-month preva-
lence and once for lifetime prevalence, re-
vealed a lack of understanding by the sub-
jects; four out of five subjects who report-
ed an infection of the kidney or renal pel-
vis in the past 12-months did not report 
such an infection as lifetime infection di-
agnosed by a physician. We conclude that 
the question is asking for an answer a lay 
person does not know. The subjects do 
either not know what an infection of the 
kidney or renal pelvis is or had this infec-
tion not diagnosed by a physician.
Section 4 requests information about 
the prescription of antibiotics as a proxy 
for antibiotic use as an indicator for the 
severity of an infectious disease. Howev-
er, this monitoring out of context does 
not allow an attribution for which infec-
tion the antibiotics were prescribed. Cross 
referencing antibiotic prescriptions with 
out-patient and in-patient care in the last 
12 months as shown in . Fig. 2, revealed 
a discrepancy: 41 % of the subjects who 
self-reported having received an antibiot-
ic prescription, did not report any contact 
to a physician. An additional 9 % were in 
the hospital but unrelated to an infection 
according to self-disclosure. Several con-
clusions can be drawn from these results. 
One is that subjects might not understand 
the difference between prescription and 
intake of antibiotics, assuming that intake 
of antibiotics (e.g. left-overs from previ-
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Table 2  Cumulative prevalence/lifetime prevalence of infectious diseases (Section 2 of the ID Screen) by study center
Total: Bremen (HB) Hamburg (HH) Heidelberg (HD) Freiburg (FR) χ2 test/Fisher’s exact 
test* n = 84 n = 91 n = 106 n = 156
%; [CI95 %] %; [CI95 %] %; [CI95 %] %; [CI95 %]
Sepsis 9.5; [4.9–17.7] 5.5; [2.4–12.2] 5.7; [2.6–11.8] 6.4; [3.5–11.4] p = 0.910
Sexually transmitted 
infections (without HIV)
11.9; [6.6–20.5] 7.7; [3.8–15.09] 5.7; [2.6–11.8] 3.9; [1.8–8.1]  p = 0.390
Infection of bones 0 0 0.9; [0.2–5.2] 1.3; [0.4–4.6] p = 0.980*
Infection of joints 3.6; [1.2–10.0]  6.6; [3.1–13.6]  7.6; [3.9–14.2]  5.8; [3.1–10.6]  p = 0.880
Infection of the heart 0 0 1,9; [0.5–6.6] 0 p = 0.650*
Infection of the kidney 9.5; [4.9–17.7] 4.4; [1.7–10.8] 3.8; [1.5–9.3] 5.1; [2.6–9.8] p = 0.520
HIV 0 0 0 0 p = 1
Chickenpox 41.7; [31.7–52.3]**† 53.9; [43.7–63.7] 55.7; [46.2–64.8] † 59.6; [51.8–67.0]** p = 0.027
**p = 0.003 (HB–FR)
†p = 0.025 (HB–HD)
Shingles 2.4; [0.7–8.3] 11.0; [6.1–19.1] 10.4; [5.9–17.6] 9.0; [5.4–14.5] p = 0.210
The differences between the study centers are not significant except for chickenpox
*Estimation with Fisher’s exact test for small cell numbers; **p-value between Bremen and Freiburg; †p-value between Bremen and Heidelberg
HIV human immunodeficiency virus, ous prescriptions) was counted as well. In 
addition, participants might not know in 
case of a hospitalization if they received 
antibiotics or not. The item assessing an-
tibiotic prescriptions used examples for 
common antibiotics; however, the time 
frame referred to the past 12 months and 
subjects might not remember if or when 
they were prescribed antibiotics.
Reliability
The most common method to test for re-
liability is the test–retest reliability. With 
the application of both the ID Screen and 
the core questionnaire of the GNC in Pre-
test 1, three questions were asked twice. 
For two variables Cohens’ κ was between 
0.61 and 0.80 and the reliability therefore 
substantial. For the two items assessing 
chickenpox Cohen’s κ was moderate. The 
participants’ uncertainty about answering 
childhood diseases was also reflected in 
the high number of missing values for this 
item. An even greater degree of uncertain-
ty could be observed for the assessment of 
vaccinations, which underscores the need 
to capture vaccination history on the ba-
sis of vaccination certificates (see Schultze 
et al. this issue).
Comparison of the acquired data for 
lifetime infections revealed differenc-
es among the study centers for all except 
chickenpox the insignificant p-values al-
low the interpretation that the ID Screen 
is producing a robust response. For chick-
enpox these deviations confirm the un-
certainty about answering childhood dis-
eases.
Construct validity
A very important aspect of a question-
naire is its ability to measure the intended 
constructs completely. For the ID Screen 
two of these constructs are “susceptibility 
to infections” and “immune status”.
The inter-item correlation for the sev-
en variables “12-month prevalence of in-
fections” is unacceptable with a Cron-
bach’s α of 0.36. This leads to the inter-
pretation that these variables do not mea-
sure a latent construct, which results in a 
score for susceptibility to infections. This 
is confirmed by the factor analysis us-
ing the same variables. With a KMO of 
0.50 the obtained score for susceptibili-
ty is barely acceptable for further analy-
sis. The main factor loadings are the more 
common gastrointestinal infections, uri-
nary tract infections and upper respirato-
ry infections with kidney infections as the 
least frequent infection, loading the low-
est. The factor can consequently be inter-
preted as frequency of infections instead 
of susceptibility to infection. A score, 
built over the sum of infections occurring 
in the past 12 months, has a similar result 
and the advantage that none of the sub-
jects are omitted due to missing data (da-
ta not shown).
As different infections are caused by 
very different bacteria and viruses, which 
the immune system has different mech-
anism to fight against, it is not surpris-
ing that a factor comprising only the 
12-month prevalence for 7 infections can-
not adequately measure susceptibility.
The variables identified and expected 
to explain “immune status” within one 
score (see methods) may not fulfill this 
aim as apparent by the low inter-item 
correlation of 0.43. More variables might 
be needed to increase the intercorrela-
tion, thereby describing a unidimension-
al construct. Clustering these variables in 
an EFA resulted in the extraction of four 
out of nine factors with an Eigenvalue > 1 
using a scree test. The KMO is with 0.6 
mediocre.
Factor loadings in . Tab. 3 show that 
none of the factors solely explains im-
mune status, and due to an unclear rela-
tionship between the items, factor nam-
ing is difficult. Factor 1 positively associ-
ates allergies with asthma and could be 
termed “allergies”. Factor 2 associates an 
allergy against drugs with the more com-
mon infections thereby describing “fre-
quency of infections”. Factor 3 clusters 
the removal of the thymus with number 
of shingles infections and an infection of 
the kidney/pelvis. However both removal 
of the thymus and 12-month prevalence of 
infection of the kidney/pelvis have a very 
low frequency, which might explain their 
grouping in a factor “rare occurrences”. 
Factor 4 clearly associates the more com-
mon surgical removal of tonsils and ad-
enoid glands with ever had an operation 
and represents “operations”.
Including dichotomous variables in a 
factor analysis is acceptable when they can 
be interpreted as a latent linear item, as is 
the case for having had an infection, no 
(0) or yes (1). However, including these 
variables leads to the extraction of more 
factors, which might explain the occur-
rence of nine factors with an Eigenvalue 
> 1. Nevertheless, the extracted four fac-
tors clearly do not explain the immune 
status, but solely aspects thereof. Especial-
ly the absence of diseases clearly associat-
ed with a defect in the immune response, 
rheumatic diseases, autoimmune diseases 
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Fig. 3 8 Distribution of the score assessing susceptibility to infections. Every subject with a factor val-
ue > 1.579 belongs to the group of the top 5 % and is considered to be highly susceptible for infec-
tions. This is the case for 21 subjects
 and diseases of the skin, like neuroderma-
titis, shows that with the current variables 
available, it is not possible to measure the 
“immune status”.
Limitations
A typical validation study allows the mea-
sure of a new instrument against a gold 
standard. For a questionnaire assessing 
medical aspects, this can be the verifica-
tion of answers against medical records, 
comparison with an already validated 
questionnaire or the measurement of suit-
able biomarkers. Due to the design of Pre-
test 1 as a feasibility study instead of a val-
idation study, certain limitations like the 
impossibility of matching ID Screen an-
swers with medical records were unavoid-
able. Furthermore, the infections assessed 
in section 1 are not typically associated 
with a doctor’s visit which would allow 
verification by medical records. To be able 
to control for information bias, a meth-
od allowing more frequent assessment of 
common infections (e.g. weekly) will be 
presented by Mall et al. in this issue.
To consider further aspects of external 
validity, like reliability and reproducibili-
ty, a reliability study was conducted dur-
ing Pretest 2 (see Castell et al., this issue).
Due to possible selection bias and lim-
ited sample size, our results might be bi-
ased. Hence, the results might not be rep-
resentative for different populations and 
should be interpreted with caution.
Conclusion
The evaluation of the ID Screen revealed 
that this questionnaire is a suitable, short 
self-report tool when applied on-site in 
the study center and can measure infec-
tions; however, resistance factors like an-
tibiotic prescriptions and hospitalization 
are not measured adequately.
One main concern is the complete as-
sessment of risk factors and missing 
items to build a score for susceptibility 
and immune status. On the contrary, we 
identified unnecessary questions which 
could be removed from a revised version 
of the ID Screen in the benefit of time.
Therefore the following modifications 
and additions are recommended:
1.  Removal of the question for 12 
months or lifetime prevalence of kid-
ney infections. The prevalence for 
both questions is very low, while the 
uncertainty and the chance of giving 
a false statement are very high.
2.  Keeping the request for the lifetime 
prevalence for sepsis, STIs and HIV 
while removing the others. The above 
mentioned infections have either a 
good and reliable response rate or 
are indicators for the success of pre-
vention measures or both. The items 
to be removed are difficult to under-
stand, unreliable or too specific for a 
common questionnaire.
3.  Pose the question for out-patient and 
in-patient care below the relevant 
12-month prevalence items to allow 
identification of the corresponding 
infection and to exclude health care 
visits due to other diseases.
4.  Remove the item for sick leave, as the 
subjects cannot distinguish between 
infectious and non-infectious causes.
5.  Change the item for prescription of 
antibiotics. Use the categories from 
item 1 and ask for prescription by a 
physician, for present and past intake.
6.  Simplify the request for the frequency 
of influenza vaccination. Possible an-
swers could be: “on the average every 
year”, “about every other year”, “only 
one or two times”.
7.  To measure immune status and sus-
ceptibility, more risk factors have to 
assessed, e.g. air-conditioning, hand 
hygiene, body hygiene, care of chil-
dren, the sick and elderly.
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Table 3  Factor loading for the construct “immune status”
Item Factor 1 
loading
Factor 2 
loading
Factor 3 
loading
Factor 4 
loading
Allergies:
 Hay fever 0.64
 Bee venom
 Food 0.60
 Dust mites 0.65
 Animal hair 0.78
 Contact allergy
 Drug allergy 0.44
Rheumatic diseases
Autoimmune diseases
Diseases of the skin
Asthma 0.47
Surgical removal of:
 Tonsils 0.61
 Adenoid glands 0.48
 Appendix
 Thymus 0.78
Number of shingle infections 0.46
Ever had an operation 0.60
12-month prevalence of infections:
Upper respiratory tract infections 0.55
Lower respiratory tract infections
Gastro-intestinal tract infections 0.65
Herpes
Furuncle 0.43
Urinary tract infections 0.61
Kidney/pelvis 0.76
To calculate a score for “immune status”, 25 items were included in an EFA. Four factors were extracted following 
scree test criteria. Presented are only factor loadings > 0.40 or < − 0.40Corresponding address
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